Cargando…

SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies

SCY-078 is an orally bioavailable ß-1,3-glucan synthesis inhibitor (GSI) and the first-in-class of structurally novel triterpene antifungals in clinical development for treating candidemia and invasive candidiasis. In vitro susceptibilities by broth microdilution, antifungal carryover, and time-kill...

Descripción completa

Detalles Bibliográficos
Autores principales: Scorneaux, Bernard, Angulo, David, Borroto-Esoda, Katyna, Ghannoum, Mahmoud, Peel, Michael, Wring, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328566/
https://www.ncbi.nlm.nih.gov/pubmed/28069658
http://dx.doi.org/10.1128/AAC.01961-16
_version_ 1782510910755045376
author Scorneaux, Bernard
Angulo, David
Borroto-Esoda, Katyna
Ghannoum, Mahmoud
Peel, Michael
Wring, Stephen
author_facet Scorneaux, Bernard
Angulo, David
Borroto-Esoda, Katyna
Ghannoum, Mahmoud
Peel, Michael
Wring, Stephen
author_sort Scorneaux, Bernard
collection PubMed
description SCY-078 is an orally bioavailable ß-1,3-glucan synthesis inhibitor (GSI) and the first-in-class of structurally novel triterpene antifungals in clinical development for treating candidemia and invasive candidiasis. In vitro susceptibilities by broth microdilution, antifungal carryover, and time-kill dynamics were determined for three reference (ATCC) strains (Candida albicans 90028, Candida parapsilosis 90018, and Candida tropicalis 750), a quality-control (QC) strain (Candida krusei 6258), and four other strains (C. albicans MYA-2732, 64124, and 76485 and Candida glabrata 90030). Caspofungin (CASP), fluconazole (FLC), and voriconazole (VRC) were comparators. For time-kill experiments, SCY-078 and CASP were evaluated at 0.25, 1, 2, 4, 8, and 16 times the MIC(80), and FLU and VRC were evaluated at 4× MIC(80). The time to reach 50%, 90%, and 99.9% reduction in the number of CFUs from the starting inoculum was determined. Net change in the number of CFU per milliliter was used to determine 50% and 90% effective concentrations and maximum effect (EC(50), EC(90), and E(max), respectively). The SCY-078 MIC range was between 0.0625 and 1 μg/ml and generally similar to that of CASP. Antifungal carryover was not observed for SCY-078. SCY-078 was fungicidal against seven isolates at ≥4× MIC (kill of ≥3 log(10)) and achieved a 1.7-log(10) reduction in CFU count/milliliter against C. albicans 90028. CASP behaved similarly against each isolate and achieved a 1.5-log(10) reduction in the number of CFU/milliliter against C. albicans 90028. Reductions of 50% in CFU count/milliliter were achieved rapidly (1 to 2.8 h); fungicidal endpoints were reached at 12.1 to 21.8 h at ≥4× MIC. EC(90) was reached at ∼5× MIC at each time point to 24 h. The EC(50) and EC(90) values were generally similar (8 to 24 h). Time-kill behavior of CASP was similar to that of SCY-078. FLC and VRC were fungistatic. Overall, SCY-078 has primarily fungicidal activity against Candida spp. and behaved comparably to CASP.
format Online
Article
Text
id pubmed-5328566
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-53285662017-03-09 SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies Scorneaux, Bernard Angulo, David Borroto-Esoda, Katyna Ghannoum, Mahmoud Peel, Michael Wring, Stephen Antimicrob Agents Chemother Pharmacology SCY-078 is an orally bioavailable ß-1,3-glucan synthesis inhibitor (GSI) and the first-in-class of structurally novel triterpene antifungals in clinical development for treating candidemia and invasive candidiasis. In vitro susceptibilities by broth microdilution, antifungal carryover, and time-kill dynamics were determined for three reference (ATCC) strains (Candida albicans 90028, Candida parapsilosis 90018, and Candida tropicalis 750), a quality-control (QC) strain (Candida krusei 6258), and four other strains (C. albicans MYA-2732, 64124, and 76485 and Candida glabrata 90030). Caspofungin (CASP), fluconazole (FLC), and voriconazole (VRC) were comparators. For time-kill experiments, SCY-078 and CASP were evaluated at 0.25, 1, 2, 4, 8, and 16 times the MIC(80), and FLU and VRC were evaluated at 4× MIC(80). The time to reach 50%, 90%, and 99.9% reduction in the number of CFUs from the starting inoculum was determined. Net change in the number of CFU per milliliter was used to determine 50% and 90% effective concentrations and maximum effect (EC(50), EC(90), and E(max), respectively). The SCY-078 MIC range was between 0.0625 and 1 μg/ml and generally similar to that of CASP. Antifungal carryover was not observed for SCY-078. SCY-078 was fungicidal against seven isolates at ≥4× MIC (kill of ≥3 log(10)) and achieved a 1.7-log(10) reduction in CFU count/milliliter against C. albicans 90028. CASP behaved similarly against each isolate and achieved a 1.5-log(10) reduction in the number of CFU/milliliter against C. albicans 90028. Reductions of 50% in CFU count/milliliter were achieved rapidly (1 to 2.8 h); fungicidal endpoints were reached at 12.1 to 21.8 h at ≥4× MIC. EC(90) was reached at ∼5× MIC at each time point to 24 h. The EC(50) and EC(90) values were generally similar (8 to 24 h). Time-kill behavior of CASP was similar to that of SCY-078. FLC and VRC were fungistatic. Overall, SCY-078 has primarily fungicidal activity against Candida spp. and behaved comparably to CASP. American Society for Microbiology 2017-02-23 /pmc/articles/PMC5328566/ /pubmed/28069658 http://dx.doi.org/10.1128/AAC.01961-16 Text en Copyright © 2017 Scorneaux et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Pharmacology
Scorneaux, Bernard
Angulo, David
Borroto-Esoda, Katyna
Ghannoum, Mahmoud
Peel, Michael
Wring, Stephen
SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies
title SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies
title_full SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies
title_fullStr SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies
title_full_unstemmed SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies
title_short SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies
title_sort scy-078 is fungicidal against candida species in time-kill studies
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328566/
https://www.ncbi.nlm.nih.gov/pubmed/28069658
http://dx.doi.org/10.1128/AAC.01961-16
work_keys_str_mv AT scorneauxbernard scy078isfungicidalagainstcandidaspeciesintimekillstudies
AT angulodavid scy078isfungicidalagainstcandidaspeciesintimekillstudies
AT borrotoesodakatyna scy078isfungicidalagainstcandidaspeciesintimekillstudies
AT ghannoummahmoud scy078isfungicidalagainstcandidaspeciesintimekillstudies
AT peelmichael scy078isfungicidalagainstcandidaspeciesintimekillstudies
AT wringstephen scy078isfungicidalagainstcandidaspeciesintimekillstudies